APA (7th ed.) Citation

Kiem, D., Leisch, M., Toth, I., Mayer, M., Pleyer, L., Greil, R., . . . Melchardt, T. (2025). Momelotinib Is Effective in Treatment for VEXAS Syndrome: Two Cases Within the AGMT Austrian Myeloid Registry. European Journal of Haematology, 115(3), 299. https://doi.org/10.1111/ejh.14445

Chicago Style (17th ed.) Citation

Kiem, Dominik, Michael Leisch, Ildiko Toth, Marie‐Christina Mayer, Lisa Pleyer, Richard Greil, Alexander Egle, and Thomas Melchardt. "Momelotinib Is Effective in Treatment for VEXAS Syndrome: Two Cases Within the AGMT Austrian Myeloid Registry." European Journal of Haematology 115, no. 3 (2025): 299. https://doi.org/10.1111/ejh.14445.

MLA (9th ed.) Citation

Kiem, Dominik, et al. "Momelotinib Is Effective in Treatment for VEXAS Syndrome: Two Cases Within the AGMT Austrian Myeloid Registry." European Journal of Haematology, vol. 115, no. 3, 2025, p. 299, https://doi.org/10.1111/ejh.14445.